Patent & IP news for January 13, 2015

Patent Litigations

USPTO Weekly Stats


Patent & IP Blogs

post image BREAKING NEWS: someone wants to register 'Je suis Charlie' as a trade mark from

Via @markmatter_ and @Loeffel_Abrar comes a piece of news that will be discussed more at length a bit later today. It concerns an application that has just been filed to register 'Je suis charlie' as ...

Share via E–mail | Twitter | Facebook

post image Best vehicle for broadening patent protection from

Bottom line: Filing a continuing patent application is the best vehicle for broadening patent protection (i.e., patent’s claim), not reissue patent applications.  In a broadening reissue patent application, the patent’s claims cannot ...

Share via E–mail | Twitter | Facebook

post image Lions, unicorns and the prospect of a licence from

Among the various odds and ends that have crossed this Kat's line of vision of late is a link to a very official-looking web page entitled "Use of the Intellectual Property Office logo" here ...

Share via E–mail | Twitter | Facebook

post image Big, green and understated: the new Modern Law of Patents from

Sometimes you put in a ton of effort, over and above the call of duty, and find yourself asking "is it all worth the hassle?"  Authors of books published by LexisNexis may well be in ...

Share via E–mail | Twitter | Facebook

post image China’s IP journey: from ‘bad guys’ to ‘good guys’ to patent superpower from

The purpose of this post is look at the development of the Chinese patent system and how China has made the transition from being a ‘pirate’ nation to a ‘protector’ of patent rights, acquiring a ...

Share via E–mail | Twitter | Facebook

IP Intensive: Experiencing the Heart of the Legal Technology Boom at CodeX from

This fall semester I had the honour of attending CodeX: The Stanford Center for Legal Informatics as part of Osgoode’s Intellectual Property Law and Technology Intensive Program.  CodeX’s broad mission is to design ...

Share via E–mail | Twitter | Facebook

Guest Post: 41 New Drugs Approved in '14 -- A Random Spike or a Growing Trend of Drug Innovation? from

By Cambria Alpha-Cobb* and Anthony D. Sabatelli** -- If innovation drives progress, then 2014 was the year of progress! During the past year the U.S. Food and Drug Administration approved 41 new drugs. That is ...

Share via E–mail | Twitter | Facebook

CARICOM, Trans-Pacific Partnership Agreement, IP Law And Policy: What Next? from

The year 2015 has dawned as usual with the fanfare of greater things to come. Caribbean projects are in the pipeline, along with activities to enhance competitiveness and many gallant efforts by well- meaning non-governmental ...

Share via E–mail | Twitter | Facebook

Panels Look At Proposed EU, French Trade Secret Legislations from

PARIS – French government officials and industry representatives gathered here recently to debate proposed new rules to protect trade secrets against unlawful acquisition, use and disclosure.

Share via E–mail | Twitter | Facebook

Defendant’s False Representation as to Use of Source Code Triggers Crime-Fraud Exception Requiring Production of Privileged Communications from

The court granted in part plaintiff's motion to compel the production of privileged documents under the crime-fraud exception to determine whether source code asserted as a defense to plaintiff's infringement claims was fabricated ...

Share via E–mail | Twitter | Facebook

Responsible Patent Licensing is Focus of NY Financial Conference from

Executives of top patent holders will participate in “NPE 2015: The Business of Responsible Licensing” to be held in NYC’s financial district on March 12. There are still some audiences that believe that NPE ...

Share via E–mail | Twitter | Facebook

Bard v. W.L. Gore: Revisiting Willful Infringement (Again) from

By Jason Rantanen Bard Peripheral Vascular, Inc. v. W.L. Gore & Associates, Inc. (Fed. Cir. 2015) 14-1114.Opinion.1-7-2015.1 Panel: Prost (author), Hughes (concurring), Newman (dissenting) Professor Tom Cotter has an excellent write-up of ...

Share via E–mail | Twitter | Facebook

Federal Appeals Court Directs FDA to Treat Reissue Patents as Separate and Distinct When Determining Eligibility for Pre-MMA 180-Day Exclusivity from

In Mylan Pharm., Inc. v. FDA, generic drug manufacturer Mylan Pharmaceuticals, Inc. (“Mylan”) challenged an FDA letter decision describing the agency’s treatment of original and reissue patents as “a single bundle of patent rights ...

Share via E–mail | Twitter | Facebook

Google Looks to Narrow both Copyrights and Patents through Supreme Court Action from

by Dennis Crouch Two pending Supreme Court now have higher profiles with the Supreme Court’s invitation to the Solicitor General to provide views of the administration.  In both cases, the petitioners have set-up the ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2015 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact